コンテンツへスキップ
Merck

Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus.

Journal of immunology (Baltimore, Md. : 1950) (2014-09-17)
Young-Nan Cho, Seung-Jung Kee, Tae-Jong Kim, Hye Mi Jin, Moon-Ju Kim, Hyun-Ju Jung, Ki-Jeong Park, Sung-Ji Lee, Shin-Seok Lee, Yong-Soo Kwon, Hae Jin Kee, Nacksung Kim, Yong-Wook Park
要旨

Mucosal-associated invariant T (MAIT) cells contribute to protection against certain microorganism infections and play an important role in mucosal immunity. However, the role of MAIT cells remains enigmatic in autoimmune diseases. In this study, we examined the level and function of MAIT cells in patients with rheumatic diseases. MAIT cell, cytokine, and programmed death-1 (PD-1) levels were measured by flow cytometry. Circulating MAIT cell levels were significantly reduced in systemic lupus erythematosus (SLE) and rheumatoid arthritis patients. In particular, this MAIT cell deficiency was more prominent in CD8(+) and double-negative T cell subsets, and significantly correlated with disease activity, such as SLE disease activity index and 28-joint disease activity score. Interestingly, MAIT cell frequency was significantly correlated with NKT cell frequency in SLE patients. IFN-γ production in MAIT cells was impaired in SLE patients, which was due to an intrinsic defect in the Ca(2+)/calcineurin/NFAT1 signaling pathway. In SLE patients, MAIT cells were poorly activated by α-galactosylceramide-stimulated NKT cells, thereby showing the dysfunction between MAIT cells and NKT cells. Notably, an elevated expression of PD-1 in MAIT cells and NKT cells was associated with SLE. In rheumatoid arthritis patients, MAIT cell levels were significantly higher in synovial fluid than in peripheral blood. Our study primarily demonstrates that MAIT cells are numerically and functionally deficient in SLE. In addition, we report a novel finding that this MAIT cell deficiency is associated with NKT cell deficiency and elevated PD-1 expression. These abnormalities possibly contribute to dysregulated mucosal immunity in SLE.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ジメチルスルホキシド, Hybri-Max, sterile-filtered, BioReagent, suitable for hybridoma, ≥99.7%
Sigma-Aldrich
ジメチルスルホキシド, ACS reagent, ≥99.9%
Sigma-Aldrich
ジメチルスルホキシド, for molecular biology
Sigma-Aldrich
ジメチルスルホキシド, suitable for HPLC, ≥99.7%
Sigma-Aldrich
ジメチルスルホキシド, sterile-filtered, BioPerformance Certified, meets EP, USP testing specifications, suitable for hybridoma
Sigma-Aldrich
ジメチルスルホキシド, ReagentPlus®, ≥99.5%
Sigma-Aldrich
ジメチルスルホキシド, ≥99.5% (GC), suitable for plant cell culture
Sigma-Aldrich
ジメチルスルホキシド, puriss. p.a., ACS reagent, ≥99.9% (GC)
Sigma-Aldrich
ジメチルスルホキシド, BioUltra, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
ブレフェルジンA, from Penicillium brefeldianum, ≥99% (HPLC and TLC)
Sigma-Aldrich
シクロスポリンA, 97.0-101.5% (on dried basis)
Sigma-Aldrich
ジメチルスルホキシド, PCR Reagent
Sigma-Aldrich
ブレフェルジンA, ≥99% (HPLC and TLC), BioXtra, for molecular biology
Sigma-Aldrich
ジメチルスルホキシド, puriss. p.a., dried, ≤0.02% water
Sigma-Aldrich
ジメチルスルホキシド, anhydrous, ≥99.9%
Sigma-Aldrich
シクロスポリンA, from Tolypocladium inflatum, ≥95% (HPLC), solid
Sigma-Aldrich
ブレフェルジンA, from Penicillium brefeldianum, Ready Made Solution, 10 mg/mL in DMSO
Sigma-Aldrich
シクロスポリンA, BioReagent, from Tolypocladium inflatum, for molecular biology, ≥95%
USP
ジメチルスルホキシド, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
ジメチルスルホキシド, meets EP testing specifications, meets USP testing specifications
Sigma-Aldrich
ジメチルスルホキシド, ≥99.5%
Sigma-Aldrich
8-Octanoyloxypyrene-1,3,6-trisulfonic acid trisodium salt, suitable for fluorescence, ≥90% (HPCE)
Sigma-Aldrich
ジメチルスルホキシド, JIS special grade, ≥99.0%
Sigma-Aldrich
ジメチルスルホキシド 溶液, 50 wt. % in H2O
Supelco
シクロスポリン, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
ジメチルスルホキシド, analytical standard
Sigma-Aldrich
ジメチルスルホキシド, Vetec, reagent grade, 99%
Sigma-Aldrich
ジメチルスルホキシド, suitable for HPLC
Sigma-Aldrich
ジメチルスルホキシド, SAJ first grade, ≥99.0%
Sigma-Aldrich
ジメチルスルホキシド, ≥99.0%, suitable for absorption spectrum analysis